Last Close
5.62 $
Jul 7, 26
Market Cap
723.9 M $
Q1 2026 (TTM)
52-Week Range
%+284.9
%96.3
1.40
2.09
%0.0
-%36.6
1M
+28.9%
3M
+49.9%
6M
+112.1%
YTD
+86.7%
1Y
+284.9%
3Y
-45.2%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
ACRS last closed at 5.62 $ (Jul 7, 26). Price data is refreshed after every trading day.
Aclaris Therapeutics Inc (ACRS) has a market capitalization of approximately 723.9 M $ as of the latest reported period.
Key peers of Aclaris Therapeutics Inc include Mesoblast Ltd, TELIX Pharmaceuticals Ltd, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., CSL Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.